Quality of Life Research

, Volume 27, Issue 8, pp 1985–2006 | Cite as

Systematic review of quality of life in Turner syndrome

  • Carolina Trombeta ReisEmail author
  • Maíra Seabra de Assumpção
  • Gil Guerra-Junior
  • Sofia Helena Valente de Lemos-Marini



This study aimed to systematically review the available literature on “quality of life” (QoL) or “health-related quality of life” (HRQoL) in Turner syndrome (TS) patients and to analyze the relations among height, puberty, and the use of growth hormone (GH) and the QoL of TS patients.


An electronic bibliographic search was conducted through the PubMed, Embase, Bireme, Scopus, and Web of Science databases. The main terms were “Quality of Life” and “Turner syndrome.”


Among the databases, 559 articles were found; after the selection process, 13 studies were selected. A quality assessment was conducted, and all the studies were of high quality. Eight well-known QoL questionnaires were used, and the selected studies presented factors that may be related to the QoL of TS patients, such as height, puberty, and GH use. However, a more detailed understanding of which factors are associated with the QoL of TS patients is still needed, which may be due to the lack of specific QoL instruments involving important aspects related to TS.


The QoL of TS patients appears to be compromised, but existing data regarding the relations among height, puberty, and GH and QoL are still controversial. Although these factors should be carefully considered in TS patients, it was not possible to determine whether they have a significant relation with the QoL of TS patients.


Quality of life Turner syndrome Body height Puberty Growth hormone 



This study was funded by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Doctoral Fellowship Number 140965/2015-7.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.


  1. 1.
    Baena, N., Vigan, C., Cariati, E., Clementi, M., Stoll, C., Caballín, M., et al. (2004). Turner syndrome: Evaluation of prenatal diagnosis in 19 European registries. American Journal of Medical Genetics, 129(A), 16–20. Scholar
  2. 2.
    Jacobs, P., Dalton, P., James, R., Mosse, K., Power, M., & Robinson, D. (1997). Turner syndrome: A cytogenetic and molecular study. Annals of Human Genetics, 61, 471–483.CrossRefPubMedGoogle Scholar
  3. 3.
    Nielsen, J., & Wohlert, M. (1990). Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Birth Defects Original Article Series, 26(4), 209–223.PubMedGoogle Scholar
  4. 4.
    Sybert, V. P., & McCauley, E. (2004). Turner’s syndrome. New England Journal of Medicine, 351, 1227–1238.CrossRefPubMedGoogle Scholar
  5. 5.
    Bondy, C. A. (2006). Turner’s syndrome and X chromosome - based differences in disease susceptibility. Gender Medicine, 3(1), 18–30.CrossRefPubMedGoogle Scholar
  6. 6.
    Donaldson, M. D. C., Gault, E. J., Tan, K. W., & Dunger, D. B. (2006). Optimising management in Turner syndrome: from infancy to adult transfer. Archives of Disease in Childhood, 91, 513–520.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Power, T., Langlois, N. E. I., & Byard, R. W. (2014). The forensic implications of Turner’s syndrome. Journal of Forensic Sciences, 59(3), 671–675.CrossRefPubMedGoogle Scholar
  8. 8.
    Wang, S., Yang, L., Li, J., & Mu, Y. (2015). Concurrent insulinoma with mosaic Turner syndrome: A case report. Experimental and Therapeutic Medicine, 9, 801–804.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Gawlik, A., & Malecka-Tendera, E. (2014). Treatment of Turner’s syndrome during transition. European Journal of Endocrinology, 170, R57-R74.CrossRefGoogle Scholar
  10. 10.
    Giordano, R., Forno, D., Lanfranco, F., Manieri, C., Ghizzoni, L., & Ghigo, E. (2011). Metabolic and cardiovascular outcomes in a group of adult patients with Turner’s syndrome under hormonal replacement therapy. European Journal of Endocrinology, 164, 819–826.CrossRefPubMedGoogle Scholar
  11. 11.
    Levitsky, L. L., Luria, A. H. O., Hayes, F. J., & Lin, A. E. (2015). Turner syndrome: Update on biology and management across the life span. Current Opinion in Endocrinology, Diabetes and Obesity, 22(1):65–72.CrossRefGoogle Scholar
  12. 12.
    Lucaccioni, L., Wong, S. C., Smyth, A., Lyall, H., Dominiczak, A., Ahmed, S. F., et al. (2015). Turner syndrome—issues to consider for transition to adulthood. British Medical Bulletin, 113, 45–58.CrossRefPubMedGoogle Scholar
  13. 13.
    Hong, D., Kent, J. S., & Kesler, S. (2009). Cognitive profile of Turner syndrome. Developmental Disabilities Research Reviews, 15(4), 270–278.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Mccauley, E., Feuillan, P., Kushner, H., & Ross, J. L. (2001). Psychosocial development in adolescents with Turner syndrome. Journal of Developmental and Behavioral Pediatrics, 22(6), 360–365.CrossRefPubMedGoogle Scholar
  15. 15.
    Marzelli, M. J., Hoeft, F., Hong, D. S., & Reiss, A. L. (2011). Neuroanatomical spatial patterns in Turner syndrome. NeuroImage, 55, 439–447.CrossRefPubMedGoogle Scholar
  16. 16.
    Cohen, J. S., & Biesecker, B. B. (2010). Quality of life in rare genetic conditions: A systematic review of the literature. American Journal of Medical Genetics, 152A(5), 1136–1156. Scholar
  17. 17.
    The WHOQOL Group. (1995). The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Social Science and Medicine, 41, 1403–1409.CrossRefGoogle Scholar
  18. 18.
    Hoxha, P., Babameto-Laku, A., Vyshka, G., Gjoka, K., Minxuri, D., Myrtaj, E., et al. (2015). Turner syndrome in Albania and the efficacy of its treatment with growth hormone. Journal of Pediatric Endocrinology and Metabolism, 28(11–12), 1227–1234.PubMedGoogle Scholar
  19. 19.
    Fekkes, M., Kamphuis, R. P., Ottenkamp, J., Verrips, E., Vogels, T., & Kamphuis, M. (2001). Health-related quality of life in young adults with minor congenital heart disease. Psychology and Health, 16, 239–251.CrossRefGoogle Scholar
  20. 20.
    Dołega, Z., Jeż, W., & Irzyniec, T. (2014). The cohort effect in studies related to differences in psychosocial functioning of women with Turner syndrome. Endokrynologia Polska, 65(4), 287–294.CrossRefPubMedGoogle Scholar
  21. 21.
    Ros, C., Alobid, I., Balasch, J., Mullol, J., & Castelo-Branco, C. (2013). Turner’s syndrome and other forms of congenital hypogonadism impair quality of life and sexual function. American Journal of Obstetrics and Gynecology, 208(6), 484.e1–484.e6.CrossRefGoogle Scholar
  22. 22.
    Cardoso, G., Daly, R., Haq, N. A., Hanton, L., Rubinow, D. R., Bondy, C. A., et al. (2004). Current and lifetime psychiatric illness in women with Turner syndrome. Gynecological Endocrinology, 19(6), 313–319.CrossRefPubMedGoogle Scholar
  23. 23.
    Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ, 339, b2535.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Fowkes, F. G. R., & Fulton, P. M. (1991). Critical appraisal of published research: introductory guidelines. BMJ, 302, 1136–1140.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Fjermestad, K. W., Naess, E. E., Bahr, D., & Gravholt, C. H. (2016). A 6-year follow-up survey of health status in middle-aged women with Turner syndrome. Clinical Endocrinology, 85, 423–429. Scholar
  26. 26.
    Freriks, K., Verhaak, C. M., Sas, T. C. J., Menke, L. A., Wit, J. M., Otten, B. J., et al. (2015). Long-term effects of oxandrolone treatment in childhood on neurocognition, quality of life and social - emotional functioning in young adults with Turner syndrome. Hormones and Behavior, 69, 59–67.CrossRefPubMedGoogle Scholar
  27. 27.
    Nadeem, M., & Roche, E. F. (2014). Health-related quality of life in Turner syndrome and the influence of key features. Journal of Pediatric Endocrinology and Metabolism, 27(3–4), 283–289.PubMedGoogle Scholar
  28. 28.
    Taback, S. P., & Van Vliet, G. (2011). Health-related quality of life of young adults with Turner syndrome following a long-term randomized controlled trial of recombinant human growth hormone. BMC Pediatrics, 11, 49.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Lasaite, L., Lašiene, D., & Lašas, L. (2010). Cognition, emotions and quality of life in Lithuanian girls with Turner syndrome after growth hormone therapy discontinuation. Journal of Pediatric Endocrinology and Metabolism, 23(5), 443–450.CrossRefPubMedGoogle Scholar
  30. 30.
    Amundson, E., Boman, U. W., Barrenas, M. L., Bryman, I., & Landin-Wilhelmsen, K. (2010). Impact of growth hormone therapy on quality of life in adults with Turner syndrome. Journal of Clinical Endocrinology and Metabolism, 95, 1355–1359.CrossRefPubMedGoogle Scholar
  31. 31.
    Naess, E. E., Bahr, D., & Gravholt, C. H. (2010). Health status in women with Turner syndrome—a questionnaire study on health status, education, work participation and aspects of sexual functioning. Clinical Endocrinology, 72, 678–684. Scholar
  32. 32.
    Zuckerman-Levin, N., Frolova-Bishara, T., Militianu, D., Levin, M., Aharon-Peretz, J., & Hochberg, Z. (2009). Androgen replacement therapy in turner syndrome: A pilot study. Journal of Clinical Endocrinology and Metabolism, 94(12), 4820–4827.CrossRefPubMedGoogle Scholar
  33. 33.
    Bannink, E. M., Raat, H., Mulder, P. G. H., & Keizer-schrama, S. M. P. F. M. (2006). Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome. The Journal of Pediatrics, 148, 678–684.CrossRefGoogle Scholar
  34. 34.
    Carel, J. C., Elie, C., Ecosse, E., Tauber, M., Léger, J., Sylvie, & Cabrol (2006). Self-esteem and social adjustment in young women with Turner syndrome- influence of pubertal management and sexuality: Population- based cohort study. Journal of Clinical Endocrinology and Metabolism, 91(80), 2972–2979.CrossRefPubMedGoogle Scholar
  35. 35.
    Carel, J. C., Ecosse, E., Bastie-Sigeac, I., Cabrol, S., Tauber, M., Leger, J., et al. (2005). Quality of life determinants in young women with Turner’s syndrome after growth hormone treatment: Results of the StaTur population-based cohort study. Journal of Clinical Endocrinology and Metabolism, 90, 1992–1997.CrossRefPubMedGoogle Scholar
  36. 36.
    Boman, U. W., Bryman, I., & Moller, A. (2004). Psychological well-being in women with Turner syndrome: Somatic and social correlates. Journal of Psychosomatic Obstetrics and Gynecology, 25, 211–219.CrossRefPubMedGoogle Scholar
  37. 37.
    Boman, U. W., Bryman, I., Halling, K., & Moller, A. (2001). Women with Turner syndrome: Psychological well-being, self-rated health and social life. Journal of Psychosomatic Obstetrics Gynecology, 22(2), 113–122.CrossRefPubMedGoogle Scholar
  38. 38.
    Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009). When does it make sense to perform a meta-analysis?, in introduction to meta-analysis. Chichester: Wiley.Google Scholar
  39. 39.
    Higgins, J.P.T, & Green, S. (Eds.)., Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from
  40. 40.
    Okada, Y. (1994). The quality of life of Turner women in comparison with grown-up GH-deficient women. Endocrine Journal, 41(4), 345–354.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.School of MedicineState University of Campinas (Unicamp)CampinasBrazil
  2. 2.Department of Pediatrics, School of MedicineState University of Campinas (Unicamp)CampinasBrazil

Personalised recommendations